Nektar Therapeutics (NKTR)

Healthcare · Biotechnology · NASDAQ

Nektar Therapeutics (NKTR) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.08B and a free-cash-flow yield of -20.3%. Over the most recent reported fiscal year, revenue declined 43.9%.

Market cap	$2.08B
Trailing P/E	—
FCF yield	-20.3%
Revenue growth (YoY)	-43.9%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live NKTR data on Nama Insights →